Skip to main content
SpringerLink
Log in

Effects of inflammation on cholesterol metabolism: Impact on systemic lupus erythematosus

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Inflammation and dysregulated cholesterol metabolism are key components in the pathogenesis of atherosclerosis. Premature atherosclerosis is a characteristic feature of systemic lupus erythematosus. Although the cellular and molecular mechanisms underlying accelerated atherogenesis in lupus are not thoroughly understood, inflammation associated with the rheumatic disease state may promote atherosclerosis. Increasing evidence indicates that the systemic inflammatory load in lupus disrupts cholesterol homeostasis, increasing vulnerability to cholesterol accumulation in cells of the artery wall, including macrophages and endothelium. The relationship between the inflammatory state and dyslipidemia in lupus is complex, involving lipoproteins, cholesterol transporters, scavenger receptors, and oxysterols. The impact of lupus on each of these components of the cholesterol flux pathways is discussed. The formation of autoantibodies against epitopes within lipoprotein particles and their controversial role in atherogenesis is addressed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Szekanecz Z, Shoenfeld Y: Lupus and cardiovascular disease: the facts. Lupus 2006, 15(Suppl 11):3–10.

    Article  Google Scholar 

  2. Wasko MC: Comorbid conditions in patients with rheumatic diseases: an update. Curr Opin Rheumatol 2004, 16:109–113.

    Article  PubMed  Google Scholar 

  3. Shoenfeld Y, Gerli R, Doria A, et al.: Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005, 112:3337–3347.

    Article  PubMed  Google Scholar 

  4. Lockshin MD, Salmon JE, Roman MJ: Atherosclerosis and lupus: a work in progress. Arthritis Rheum 2001, 44:2215–2217.

    Article  PubMed  CAS  Google Scholar 

  5. Bruce IN, Burns RJ, Gladman DD, Urowitz MB: Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. I. Prevalence and distribution of abnormalities. J Rheumatol 2000, 27:2372–2377.

    PubMed  CAS  Google Scholar 

  6. Manzi S, Meilahn EN, Rairie JE, et al.: Age-specific rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 1997, 145:408–415.

    PubMed  CAS  Google Scholar 

  7. Esdaile JM, Abrahamowicz M, Grodzicky T, et al.: Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001, 44:2331–2337.

    Article  PubMed  CAS  Google Scholar 

  8. Sharrett AR, Ballantyne CM, Coady SA, et al.: Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001, 104:1108–1113.

    Article  PubMed  CAS  Google Scholar 

  9. Borba EF, Bonfa E: Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies. Lupus 1997, 6:533–539.

    Article  PubMed  CAS  Google Scholar 

  10. Svenungsson E, Gunnarsson I, Fei GZ, et al.: Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with upregulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus. Arthritis Rheum 2003, 48:2533–2540.

    Article  PubMed  CAS  Google Scholar 

  11. Nuttall SL, Heaton S, Piper MK, et al.: Cardiovascular risk in systemic lupus erythematosus-evidence of increased oxidative stress and dyslipidaemia. Rheumatology 2003, 42:758–762.

    Article  PubMed  CAS  Google Scholar 

  12. Karp I, Abrahamowicz M, Fortin PR, et al.: Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus? Arthritis Rheum 2008, 59:169–175.

    Article  PubMed  CAS  Google Scholar 

  13. Malloy MJ, Kane JP: A risk factor for atherosclerosis: triglyceride-rich lipoproteins. Adv Intern Med 2001, 47:111–136.

    PubMed  CAS  Google Scholar 

  14. Borba EF, Bonfa E, Vinagre CG, et al.: Chylomicron metabolism is markedly altered in systemic lupus erythematosus. Arthritis Rheum 2000, 43:1033–1040.

    Article  PubMed  CAS  Google Scholar 

  15. Carr MC, Ayyobi AF, Murdoch SJ, et al.: Contribution of hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein to LDL and HDL heterogeneity in healthy women. Arterioscler Thromb Vasc Biol 2002, 22:667–673.

    Article  PubMed  CAS  Google Scholar 

  16. Reichlin M, Fesmire J, Quintero-Del-Rio AI, Wolfson-Reichlin M: Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus. Arthritis Rheum 2002, 46:2957–2963.

    Article  PubMed  CAS  Google Scholar 

  17. de Carvalho JF, Borba EF, Viana VS, et al.: Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus? Arthritis Rheum 2004, 50:3610–3615.

    Article  PubMed  Google Scholar 

  18. Studnicka-Benke A, Steiner G, Petera P, Smolen JS: Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Br J Rheumatol 1996, 35:1067–1074.

    Article  PubMed  CAS  Google Scholar 

  19. Svenungsson E, Fei GZ, Jensen-Urstad K, et al.: TNF-alpha: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease. Lupus 2003, 12:454–461.

    Article  PubMed  CAS  Google Scholar 

  20. Feingold KR, Grunfeld C: Role of cytokines in inducing hyperlipidemia. Diabetes 1992, 41(Suppl 2):97–101.

    PubMed  CAS  Google Scholar 

  21. Steinberg D, Parthasarathy S, Carew TE, et al.: Beyond cholesterol. Modification of low density lipoprotein that increase its atherogenicity. N Engl J Med 1989, 320:915–924.

    PubMed  CAS  Google Scholar 

  22. Chisolm GM, Steinberg D: The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med 2000, 28:1815–1826.

    Article  PubMed  CAS  Google Scholar 

  23. Vergnani L, Hatrik S, Ricci F, et al.: Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production: key role of L-arginine availability. Circulation 2000, 101:1261–1266.

    PubMed  CAS  Google Scholar 

  24. Meisinger C, Baumert J, Khuseyinova N, et al.: Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation 2005, 112:651–657.

    Article  PubMed  CAS  Google Scholar 

  25. Griffin BA, Freeman DJ, Tait GW, et al.: Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 1994, 106:241–253.

    Article  PubMed  CAS  Google Scholar 

  26. Lopes-Virella MF, Virella G: Atherosclerosis and autoimmunity. Clin Immunol Immunopathol 1994, 73:155–167.

    Article  PubMed  CAS  Google Scholar 

  27. Nilsson J, Hansson GK: Autoimmunity in atherosclerosis: a protective response losing control? J Intern Med 2008, 263:464–478.

    Article  PubMed  CAS  Google Scholar 

  28. Fukumoto M, Shoji T, Emoto M, et al.: Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population. Arterioscler Thromb Vasc Biol 2000, 20:703–707.

    PubMed  CAS  Google Scholar 

  29. Shoji T, Nishizawa Y, Fukumoto M, et al.: Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis 2000, 148:171–177.

    Article  PubMed  CAS  Google Scholar 

  30. Chang MK, Bergmark C, Laurila A, et al.: Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc Natl Acad Sci USA 1999, 96:6353–6358.

    Article  PubMed  CAS  Google Scholar 

  31. Matsuura E, Kobayashi K, Matsunami Y, Lopez LR: The immunology of atherothrombosis in the antiphospholipid syndrome: Antigen presentation and lipid intracellular accumulation. Autoimm Rev 2009, 8:500–505.

    Article  CAS  Google Scholar 

  32. Saad AF, Virella G, Chassereau C, et al.: OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages. J Lipid Res 2006, 47:1975–1983.

    Article  PubMed  CAS  Google Scholar 

  33. Reiss AB, Wan DW, Anwar K, et al.: Enhanced CD36 scavenger receptor expression in THP-1 human monocytes in the presence of lupus plasma: linking autoimmunity and atherosclerosis. Exp Biol Med (Maywood) 2009, 234:354–360.

    Article  CAS  Google Scholar 

  34. Klimov AN, Denisenko AD, Vinogradov AG, et al.: Accumulation of cholesteryl esters in macrophages incubated with human lipoprotein-antibody autoimmune complex. Atherosclerosis 1988, 74:41–46.

    Article  PubMed  CAS  Google Scholar 

  35. Kabakov AE, Tertov VV, Saenko VA, et al.: The atherogenic effect of lupus sera: Systemic lupus erythematosus-derived immune complexes stimulate the accumulation of cholesterol in cultured smooth muscle cells from human aorta. Clin Immunol Immunopathol 1992, 63:214–220.

    Article  PubMed  CAS  Google Scholar 

  36. Lozada C, Levin RI, Huie M, et al.: Identification of C1q as the heat-labile serum cofactor required for immune complexes to stimulate endothelial expression of the adhesion molecules E-selectin and intercellular and vascular cell adhesion molecules 1. Proc Natl Acad Sci USA 1995, 92:8378–8382.

    Article  PubMed  CAS  Google Scholar 

  37. Reiss AB, Awadallah NW, Malhotra S, et al.: Immune complexes and INF-gamma decrease cholesterol 27-hydroxylase in human arterial endothelium and macrophages. J Lipid Res 2001, 42:1913–1922.

    PubMed  CAS  Google Scholar 

  38. Reiss AB, Rahman MM, Chan ES, et al.: Adenosine A2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages. J Leukoc Biol 2004, 76:727–734.

    Article  PubMed  CAS  Google Scholar 

  39. Reiss AB, Glass AD: Atherosclerosis: immune and inflammatory aspects. J Investig Med 2006, 54:123–131.

    Article  PubMed  CAS  Google Scholar 

  40. Rust S, Rosier M, Funke H, et al.: Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 1999, 22:352–355.

    Article  PubMed  CAS  Google Scholar 

  41. Bermudez V, Cano R, Cano C, et al.: Pharmacologic management of isolated low high-density lipoprotein syndrome. Am J Ther 2008, 15:377–388.

    Article  PubMed  Google Scholar 

  42. Van Lenten BJ, Hama SY, de Beer FC, et al.: Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 1995, 96:2758–2767.

    Article  PubMed  Google Scholar 

  43. Navab M, Anantharamaiah GM, Reddy ST, et al.: Mechanisms of disease: proatherogenic HDL—an evolving field. Nat Clin Pract Endocrinol Metab 2006, 2:504–511.

    Article  PubMed  CAS  Google Scholar 

  44. Mackness B, Durrington P, McElduff P, et al.: Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation 2003, 107:2775–2779.

    Article  PubMed  CAS  Google Scholar 

  45. Delgado-Alves J, Ames PR, Donohue S, et al.: Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome. Arthritis Rheum 2002, 46:2686–2694.

    Article  PubMed  CAS  Google Scholar 

  46. Dinu AR, Merrill JT, Shen C, et al.: Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE. Lupus 1998, 7:355–360.

    Article  PubMed  CAS  Google Scholar 

  47. Batuca JR, Ames PR, Amaral M, et al.: Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus. Rheumatology (Oxford) 2009, 48:26–31.

    Article  CAS  Google Scholar 

  48. Hahn B, McMahon M: Atherosclerosis and systemic lupus erythematosus: the role of altered lipids and of autoantibodies. Lupus 2008, 17:368–370.

    Article  PubMed  CAS  Google Scholar 

  49. McMahon M, Grossman J, FitzGerald J, et al.: Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 2006, 54:2541–2549.

    Article  PubMed  CAS  Google Scholar 

  50. Urowitz MB, Gladman D, Ibanez D, et al.: Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis Rheum 2008, 59:176–180.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Vascular Biology Institute, Department of Medicine, Winthrop University Hospital, 222 Station Plaza North, Suite 502, Mineola, NY, 11501, USA

    Allison B. Reiss

Authors
  1. Allison B. Reiss
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Allison B. Reiss.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reiss, A.B. Effects of inflammation on cholesterol metabolism: Impact on systemic lupus erythematosus. Curr Rheumatol Rep 11, 255–260 (2009). https://doi.org/10.1007/s11926-009-0036-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-009-0036-y

Keywords

Search

Navigation